Potential plasma markers of type 1 and type 2 leprosy reactions: A preliminary report

BMC Infectious Diseases

Volumn 9, Issue , 2009, Pages

  Stefani, Mariane M ^a   Guerra, Jackeline G ^a   Sousa, Ana Lucia M ^a   Costa, Mauricio B ^a   Oliveira, Maria Leide W ^b   Martelli, Celina T ^a   Scollard, David M ^c  

^a FEDERAL UNIVERSITY OF GOIÁS   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BIOLOGICAL MARKER; EOTAXIN; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GRANULOCYTE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 13; INTERLEUKIN 15; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 8; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; PLATELET DERIVED GROWTH FACTOR BB; RANTES; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; CYTOKINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BRAZIL; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; ERYTHEMA NODOSUM LEPROSUM; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOPATHOLOGY; LEPROSY; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOBACTERIUM LEPRAE; REVERSAL REACTION; BLOOD; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; BIOLOGICAL MARKERS; BRAZIL; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; HUMANS; LEPROSY; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 67649205754     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-9-75     Document Type: Article

References (37)

1. Scollard DM Smith T Bhoopat L Theetranont C Rangdaeng S Morens DM Epidemiologic characteristics of leprosy reactions Int J Lepr Other Mycobact Dis 1994, 62(4):559-567. 7868954
2. Scollard DM Adams LB Gillis TP Krahenbuhl JL Truman RT Williams DL The Continuing Challenges of Leprosy Clin Microbiol Rev 2006, 19:339-381. 10.1128/CMR.19.2.338-381.2006
3. Modlin RL Melancon-Kaplan J Young SMM Pirmez C Kino H Convit J Rea TH Bloom BR Learning from lesions: Patterns of tissue inflammation in leprosy Proc Nat Acad Sci USA 1988, 85:1213-1217. 279737 3257577 10.1073/ pnas.85.4.1213
4. Moraes MO Sarno EN Almeida AS Saraiva BC Nery JA Martins RC Sampaio EP Cytokine mRNA expression in leprosy: A possible role for interferon-gamma and interleukin-12 in reactions (RR and ENL) Scand J Immunol 1999, 50:541-549. 10.1046/j.1365-3083.1999.00622.x 10564558
5. Stefani MM Martelli CM Gillis TP Krahenbuhl JL Brazilian Leprosy Study Group In situ type 1 cytokine gene expression and mechanisms associated with early leprosy progression J Infect Dis 2003, 188:1024-1031. 10.1086/ 378410 14513423
6. Sousa AL Stefani MM Pereira GA Costa MB Rebello PF Gomes MK Narahashi K Gillis TP Krahenbuhl JL Martelli CM Mycobacterium leprae DNA associated with type 1 reactions in single lesion paucibacillary leprosy treated with single dose rifampin, ofloxacin, and minocycline Am J Trop Med Hyg 2007, 77:829-833. 17984336
7. Ridley DS Jopling WH Classification of leprosy according to immunity - a five-group system Int J Lepr Other Mycobact Dis 1966, 34:255-273. 5950347
8. Kaplan G Nathan CF Gandhi R Horwitz MA Levis WR Cohn ZA Effect of recombinant interferon-g on hydrogen peroxide-releasing capacity of monocyte-derived macrophages from patients with lepromatous leprosy J Immunol 1986, 137:983-987. 3088117
9. Wenzel J Zahn S Mikus S Wiechert A Bieber T Tuting T The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets Br J Dermatol 2007, 157:752-757. 10.1111/j.1365-2133.2007.08137.x 17714558
10. Carter SL Muller M Manders PM Campbell IL Induction of the genes for Cxcl9 and Cxcl10 is dependent on IFN-gamma but shows differential cellular expression in experimental autoimmune encephalomyelitis and by astrocytes and microglia in vitro Glia 2007, 55:1728-1739. 10.1002/ glia.20587 17902170
11. Djoba Siawaya JF Ruhwald M Eugen-Olsen J Walzl G Correlates for disease progression and prognosis during concurrent HIV/TB infection Int J Infect Dis 2007, 11:289-299. 10.1016/j.ijid.2007.02.001 17446108
12. Scarpini E Galimberti D Baron P Clerici R Ronzoni M Conti G Scarlato G IP-10 and MCP-1 levels in CSF and serum from multiple sclerosis patients with different clinical subtypes of the disease J Neurol Sci 2002, 195:41-46. 10.1016/S0022-510X(01)00680-3 11867072
13. Mahad DJ Howell SJ Woodroofe MN Expression of chemokines in the CSF and correlation with clinical disease activity in patients with multiple sclerosis J Neurol Neurosurg Psychiatry 2002, 72:498-502. 1737819 11909910
14. Tanuma N Sakuma H Sasaki A Matsumoto Y Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis Acta Neuropathol 2006, 112:195-204. 10.1007/s00401-006-0083-7 16733654
15. Mastorakos G Ilias I Interleukin-6: A cytokine and/or a major modulator of the response to somatic stress Ann N Y Acad Sci 2006, 1088:373-381. 10.1196/annals.1366.021 17192581
16. Belgaumkar VA Gokhale NR Mahajan PM Bharadwaj R Pandit DP Deshpande S Circulating cytokine profiles in leprosy patients Lepr Rev 2007, 78:223-230. 18035773
17. Sieling PA Sakimura L Uyemura K Yamamura M Oliveros J Nickoloff BJ Rea TH Modlin RL IL-7 in the cell-mediated immune response to a human pathogen J Immunol 1995, 154:2775-2783. 7876548
18. Milne CD Paige CJ IL-7: A key regulator of B lymphopoiesis Semin Immunol 2006, 18:20-30. 10.1016/j.smim.2005.10.003 16303314
19. Surh CD Boyman O Purton JF Sprent J Homeostasis of memory T cells Immunol Rev 2006, 211:154-163. 10.1111/j.0105-2896.2006.00401.x 16824125
20. Mendonca VA Malaquias LC Brito-Melo GE Castelo-Branco A Antunes CM Ribeiro AL Teixeira MM Teixeira AL Differentiation of patients with leprosy from non-infected individuals by the chemokine eotaxin/CCL11 Am J Trop Med Hyg 2007, 77:547-550. 17827376
21. Bandeira-Melo C Herbst A Weller PF Eotaxins. Contributing to the diversity of eosinophil recruitment and activation Am J Respir Cell Mol Biol 2001, 24:653-657. 11415928
22. Gutierrez-Ramos JC Lloyd C Gonzalo JA Eotaxin: From an eosinophilic chemokine to a major regulator of allergic reactions Immunol Today 1999, 20:500-504. 10.1016/S0167-5699(99)01522-4 10529777
23. Moubasher AD Kamel NA Zedan H Raheem DD Cytokines in leprosy, I. Serum cytokine profile in leprosy Int J Dermatol 1998, 37:733-740. 10.1046/ j.1365-4362.1998.00381.x 9802682
24. Sreenivasan P Misra RS Wilfred D Nath I Lepromatous leprosy patients show T helper 1-like cytokine profile with differential expression of interleukin-10 during type 1 and 2 reactions Immunol 1998, 95:529-536. 10.1046/j.1365-2567.1998.00634.x
25. Yamamura M Wang XH Ohmen JD Uyemura K Rea TH Bloom BR Modlin RL Cytokine patterns of immunologically mediated tissue damage J Immunol 1992, 149:1470-1475. 1500726
26. Nath I Vemuri N Reddi AL Bharadwaj M Brooks P Colston MJ Misra RS Ramesh V Dysregulation of IL-4 expression in lepromatous leprosy patients with and without erythema nodosum leprosum Lepr Rev 2000, 71(Suppl):S130-S137. 11201870
27. Pfaltzgraff RE Bryceson A Clinical Leprosy Leprosy New York: Churchill Livingstone Hastings RC 1985:134-176.
28. Requena L Sanchez Yus E Panniculitis. Part II. Mostly lobular panniculitis J Am Acad Dermatol 2001, 45(3):325-361. 62-4. 10.1067/ mjd.2001.114735 11511831
29. Sarno EN Grau GE Vieira LMM Nery JA Serum levels of tumour necrosis factor-alpha and interleukin-1B during leprosy reactional states Clin Exp Immunol 1991, 84:103-108. 1535359 2015700
30. Sampaio EP Kaplan G Miranda A Nery JA Miguel CP Viana SM Sarno EM The influence of thalidomide on the clinical and immunologic manifestation of erythema nodosum leprosum J Infect Dis 1993, 168:408-414. 8335978
31. Barnes PF Chatterjee D Brennan PJ Rea TH Modlin RL Tumor necrosis factor production in patients with leprosy Infect Immun 1992, 60:1441-1446. 257016 1548069
32. Foss NT de Oliveira EB Silva CL Correlation between TNF production, increase of plasma C-reactive protein level and suppression of T lymphocyte response to concanavalin A during erythema nodosum leprosum Int J Lepr Other Mycobact Dis 1993, 61:218-226. 8371031
33. Bhattacharya SN Chattopadhaya D Saha K Tumor necrosis factor: Status in reactions in leprosy before and after treatment Int J Dermatol 1993, 32:436-439. 10.1111/j.1365-4362.1993.tb02816.x 8320025
34. Villahermosa LG Fajardo TT Jr Abalos RM Balagon MV Tan EV Cellona RV Palmer JP Wittes J Thomas SD Kook KA Walsh GP Walsh DS A randomized, double-blind, double-dummy, controlled dose comparison of thalidomide for treatment of erythema nodosum leprosum Am J Trop Med Hyg 2005, 72:518-526. 15891124
35. Haslett PA Roche P Butlin CR Macdonald M Shrestha N Manandhar R Lemaster J Hawksworth R Shah M Lubisnky AS Albert M Worley J Kaplan G Effective treatment of erythema nodosum leprosum with thalidomide is associated with immune stimulation J Infect Dis 2005, 192(12):2045-2053. 10.1086/ 498216 16288366
36. Andersson AK Chaduvula M Atkinson SE Khanolkar-Young S Jain S Suneetha L Lockwood DN Effects of prednisolone treatment on cytokine expression in patients with leprosy type 1 reactions Infect Immun 2005, 73(6):3725-3733. 1111887 15908402 10.1128/IAI.73.6.3725-3733.2005
37. Weaver CT Hatton RD Mangan PR Harrington LE IL-17 family cytokines and the expanding diversity of effector T cell lineages Annu Rev Immunol 2007, 25:821-852. 10.1146/annurev.immunol.25.022106.141557 17201677